Abstract
The report includes the essential therapeutic and toxic results following MOPP vs. MOPP/ABVD and MOPP vs. ABVD within a combined modality setting. The findings indicate that in stage IV the alternating regimen is superior to MOPP while in stage IIB-III ABVD plus radiotherapy yielded superior results associated with no treatment-induced sterility and leukemia compared with MOPP plus radiotherapy.
Publication types
-
Clinical Trial
-
Comparative Study
-
Randomized Controlled Trial
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Bleomycin / administration & dosage
-
Combined Modality Therapy
-
Dacarbazine / administration & dosage
-
Doxorubicin / administration & dosage
-
Hodgkin Disease / drug therapy*
-
Humans
-
Mechlorethamine / administration & dosage
-
Prednisone / administration & dosage
-
Procarbazine / administration & dosage
-
Randomized Controlled Trials as Topic
-
Vinblastine
-
Vincristine / administration & dosage
Substances
-
Bleomycin
-
Procarbazine
-
Mechlorethamine
-
Vincristine
-
Vinblastine
-
Dacarbazine
-
Doxorubicin
-
Prednisone
Supplementary concepts
-
ABVD protocol
-
MOPP protocol